-
Mexico's Sheinbaum holds huge rally following major protests
-
Salah tirade adds to Slot's troubles during Liverpool slump
-
Torres treble helps Barca extend Liga lead, Atletico slip
-
PSG thump Rennes but Lens remain top in France
-
Salah opens door to Liverpool exit with 'thrown under the bus' rant
-
Two eagles lift Straka to World Challenge lead over Scheffler
-
Messi dazzles as Miami beat Vancouver to win MLS title
-
Bielle-Biarrey strikes twice as Bordeaux-Begles win Champions Cup opener in S.Africa
-
Bilbao's Berenguer deals Atletico another Liga defeat
-
Salah opens door to Liverpool exit after being 'thrown under the bus'
-
Bethlehem Christmas tree lit up for first time since Gaza war
-
Slot shows no sign of finding answers to Liverpool slump
-
New Zealand's Robinson wins giant slalom at Mont Tremblant
-
Liverpool slump self-inflicted, says Slot
-
Hundreds in Tunisia protest against government
-
Mofokeng's first goal wins cup final for Orlando Pirates
-
Torres hat-trick helps Barca down Betis to extend Liga lead
-
Bielle-Biarrey strikes twice as Bordeaux win Champions Cup opener in S.Africa
-
Liverpool humbled again by Leeds fightback for 3-3 draw
-
'Democracy has crumbled!': Four arrested in UK Crown Jewels protest
-
Contenders plot path to 2026 World Cup glory as FIFA reveals tournament schedule
-
Inter thump Como to top Serie A ahead of Liverpool visit
-
Maresca fears Chelsea striker Delap faces fresh injury setback
-
Consistency the key to Man City title charge – Guardiola
-
Thauvin on target again as Lens remain top in France
-
Greyness and solitude: French ex-president describes prison stay
-
Frank relieved after Spurs ease pressure on under-fire boss
-
England kick off World Cup bid in Dallas as 2026 schedule confirmed
-
Milei welcomes Argentina's first F-16 fighter jets
-
No breakthrough at 'constructive' Ukraine-US talks
-
Bielle-Biarrey double helps Bordeaux-Begles open Champions Cup defence with Bulls win
-
Verstappen looking for a slice of luck to claim fifth title
-
Kane cameo hat-trick as Bayern blast past Stuttgart
-
King Kohli says 'free in mind' after stellar ODI show
-
Arsenal rocked by Aston Villa, Man City cut gap to two points
-
Crestfallen Hamilton hits new low with Q1 exit
-
Sleepless in Abu Dhabi - nervy times for Norris says Rosberg
-
Arsenal will bounce back from Villa blow: Arteta
-
UN Security Council delegation urges all sides to stick to Lebanon truce
-
Verstappen outguns McLarens to take key pole in Abu Dhabi
-
Syria's Kurds hail 'positive impact' of Turkey peace talks
-
Verstappen takes pole position for season-ending Abu Dhabi GP
-
Jaiswal hits ton as India thrash S. Africa to clinch ODI series
-
UK's Farage rallies in Scottish town hit by immigration protests
-
Saracens kick off European campaign by crushing Clermont
-
Arsenal rocked by Villa as Buendia ends leaders' unbeaten run
-
Venezuela's Machado vows to make Nobel Peace Prize ceremony
-
Kidnapping fears strain family bonds in Nigeria
-
'Chosen' Mbappe on way to making Real Madrid history like Ronaldo: Alonso
-
Russian strikes on Ukraine trigger heating, water cuts
| RBGPF | 0% | 78.35 | $ | |
| BCC | -1.66% | 73.05 | $ | |
| NGG | -0.66% | 75.41 | $ | |
| VOD | -1.31% | 12.47 | $ | |
| SCS | -0.56% | 16.14 | $ | |
| BCE | 1.4% | 23.55 | $ | |
| GSK | -0.33% | 48.41 | $ | |
| RYCEF | -0.34% | 14.62 | $ | |
| RELX | -0.55% | 40.32 | $ | |
| CMSC | -0.21% | 23.43 | $ | |
| RIO | -0.92% | 73.06 | $ | |
| JRI | 0.29% | 13.79 | $ | |
| CMSD | -0.3% | 23.25 | $ | |
| AZN | 0.17% | 90.18 | $ | |
| BTI | -1.81% | 57.01 | $ | |
| BP | -3.91% | 35.83 | $ |
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
O.Gaspar--PC